series-c-plus
Stage
1
Investors
About
Vandria is a biopharmaceutical company developing first-in-class small molecule mitophagy inducers to treat age-related and chronic diseases, including CNS, muscle, lung, and liver disorders.
Explore Vandria's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.